Published in:
01-08-2021 | Ovarian Cancer | ASO Author Reflections
ASO Author Reflections: The Frailty of Patient Selection
Authors:
Katherin Zambrano-Vera, MD, Armando Sardi, MD, FACS, Michelle Sittig, RN, Teresa Diaz-Montes, MD, MPh, FACOG
Published in:
Annals of Surgical Oncology
|
Issue 8/2021
Login to get access
Excerpt
Ovarian cancer remains a leading cause of death for women in the US and increased age has typically been associated with worse prognosis. Patients older than 65 years are more likely to undergo conservative treatments due to fear of increased morbidity and mortality.
1 Although some studies have shown age to be a poor prognostic factor for ovarian cancer,
2 it should not be considered as the most important. Variables such as feasibility of cytoreduction, frailty, and performance status may be of greater importance when selecting patients for cytoreductive surgery plus hyperthermic chemotherapy (CRS/HIPEC). …
